Empirico

About:

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

Website: http://www.empiricotx.com/

Top Investors: Ionis Pharmaceuticals, DCVC Bio, Neotribe Ventures

Description:

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.The company's platform uses biological datasets, human genetics, and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses.

Total Funding Amount:

$91.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2017-11-07

Founders:

Brian Cajes

Number of Employees:

51-100

Last Funding Date:

2023-03-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai